Evidence map

ReviewCell metabolism2023

GIPR/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications.

Jonathan E Campbell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

66 papers cite itlatest 60 shown

2023
2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 37591245